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Regulation of IL-4 Gene Expression
by Distal Regulatory Elements
and GATA-3 at the Chromatin Level
Jun B, STAT6, c-maf, and NIP45, have been found to
bind to and/or regulate the activity of the IL-4 promoter
(Brown and Hural, 1997; Li-Weber et al., 1997; Rinco´n
and Flavell, 1997; Szabo et al., 1997; Murphy, 1998).
However, it has been reported that the 800 base pair
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IL-4 promoter is not sufficient to give physiological ex-New Haven, Connecticut 06520
pression levels of reporter gene expression in IL-4 pro-
moter–luciferase transgenic mice, although it does ex-
hibit Th2 specificity (Wenner et al., 1997). This reportSummary
suggested that more distal elements in the IL-4 locus
are necessary for optimal IL-4 expression.Using a transgenic approach, we examined distal reg-
Henkel et al. (1992) reported a mast cell–specific en-ulatory elements located in the IL-4 locus and the role
hancer in the second intron of the IL-4 gene. This en-of GATA-3 at these elements. The intergenic DNase I
hancer is DNase I hypersensitive and augments IL-4hypersensitive sites (HSS) showed strong enhance-
transcription in transient transfection assays in mast cellment, and the intronic enhancer (IE) and HS5/HS5a
lines. Although the authors showed that this enhancersites showed weaker enhancement of the IL-4 pro-
does not function in the transformed T cell line EL-4moter. Elements in the 39 region of the IL-4 gene con-
(which expresses IL-4 upon activation), Agarwal andtributed to Th2 specificity. All individual enhancers
Rao (1998) subsequently showed that this region iswere T cell activation dependent but not Th2 specific,
DNase I hypersensitive in the Th2 cell line D10 and inwith the exception of IE. However, when these distal
differentiating Th2 cells from naive CD4 T cells, sug-elements were combined into a “minilocus,” expres-
gesting that the intronic enhancer might function nor-sion was strongly enhanced and Th2 specific. GATA-3
mally in nontransformed Th2 cells.mediated strong enhancement of IL-4 promoter activ-
Changes in the chromatin structure of the IL-4 locusity in Th1 cells when the promoter was embedded in
have been shown to occur during differentiation to Th1/the minilocus or linked to HSS and IE, demonstrating
Th2 cells. (Agarwal and Rao, 1998; Bird et al., 1998;that GATA-3 acts through these elements to regulate
Takemoto et al., 1998). Agarwal and Rao (1998) haveIL-4 gene expression.
shown that five DNase I hypersensitive sites, named
HS1–HS5, are induced in the vicinity of the IL-4 geneIntroduction
during Th1/Th2 differentiation. Most of the HS sites are
induced only in Th2 cells, except HS4, which is foundUpon stimulation with antigen in the appropriate envi-
in both Th1 and Th2 cells. Likewise, Takemoto et al.ronment, naive CD4 T cells differentiate into at least two
(1998) found that DNase I hypersensitive sites, nameddifferent sets of effector cells called Th1 and Th2 (Abbas
as HSS1–HSS3, develop between the IL-4 and IL-13et al., 1996). Th1 cells produce IFN-g and lymphotoxin
genes during Th1/Th2 differentiation. Of the HSS sites,a (TNFb), confer cell-mediated immunity against intra-
HSS1 and HSS2 were induced only in Th2 cells, whilecellular pathogens, and cause autoimmunity. Th2 cells
HSS3 was induced both in Th1 and Th2 cells. DNase Iproduce IL-4, IL-5, IL-10, and IL-13 and are involved in
hypersensitivity is believed to reflect localized “open”allergy, humoral immunity, and immunity to parasites.
chromatin configuration where DNA is accessible toOf the many conditions that regulate T helper cell differ-
binding by many factors (Gross, 1988). It has been
entiation, the cytokine environment is the most critical
shown that regulatory elements like tissue-specific en-
determinant of differentiation into Th1 or Th2. In the
hancers and locus control regions (LCR) are located in
presence of antigen, IL-12 drives differentiation of CD4 DNase I hypersensitive sites (Stamatoyannopoulos et
T cells to Th1 effector cells, while IL-4 drives naive T al., 1995; Boyes and Felsenfeld, 1996). Changes of meth-
cells to become Th2 effectors. ylation status have also been reported in the IL-4 and
Regulation of IL-4 gene expression is critically impor- IL-5 loci during differentiation to Th2 cells (Agarwal and
tant for the induction of Th2 cell differentiation and, Rao, 1998; Bird et al., 1998). DNA methylation has been
therefore, Th2 immune responses (reviewed by Abbas correlated with alteration in chromatin structure and
et al., 1996; Brown and Hural, 1997). So far, studies of gene silencing by changing the recognition of the double
tissue-specific IL-4 gene regulation have mainly focused helix by the transcriptional machinery and structural pro-
on the proximal IL-4 promoter region, and detailed infor- teins that assemble chromatin (reviewed by Jones and
mation has been accumulated on this region (reviewed Wolffe, 1999). These combined results of DNase I hyper-
by Brown and Hural, 1997; Li-Weber et al., 1997; Rinco´n sensitivity and DNA methylation on the Th2 cytokine
and Flavell, 1997; Szabo et al., 1997; Murphy, 1998). locus strongly suggest that Th2 cytokine genes are regu-
These studies have shown that NFAT confers TCR in- lated by mechanisms working at the chromatin level.
ducibility to the IL-4 promoter and that other factors, The candidates for the cis-acting regulatory elements
including C/EBP, NF-Y, AP-1, NF-kB, HMG I (Y), GATA-3, working at the chromatin level would be distal en-
hancers, LCRs, insulators, and silencers (Bagga et al.,
1998). Since the Th2 cytokine genes IL-4, IL-5, and IL-13‡ To whom correspondence should be addressed (e-mail: richard.
flavell@yale.edu). are clustered within a 125 kb region (Loots et al., 2000)
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and are expressed in a differentiation-specific manner, and mouse, reasoning that inter- or intragenic regulatory
it has been speculated that this Th2 cytokine locus might sequences would be conserved evolutionarily, as was
have an LCR that controls the coordinate expression of first shown for the immunoglobulin light chain enhancer
Th2 cytokine genes (Flavell, 1999). LCRs are regulatory (Emorine et al., 1983). A similar approach has recently
elements that confer tissue-specific and developmental been used by Loots et al. (2000). To assay enhancer
stage–specific high-level gene expression to linked activity, we measured the increased luciferase activity
genes without interference from flanking sequences in Th1/Th2 cells from transgenic mice carrying possible
(Grosveld et al., 1987). The best known example of an regulatory sites linked to the reporter gene compared to
LCR is in the human b-globin gene clusters (reviewed control transgenic mice carrying only the IL-4 promoter-
by Li et al., 1999; Engel and Tanimoto, 2000). The human driven reporter gene. For LCR activity, we measured
b-globin locus contains five genes and one pseudogene, luciferase activity in Th1/Th2 cells as a function of copy
the expression of which is developmentally controlled. number in the transgenic mice. We found that a cluster
The responsible element for this coordinate regulation of DNase I hypersensitive sites between the IL-13 and
is the b-globin LCR, which is composed of five DNase IL-4 genes (HSS) has strong enhancer activity on the
I hypersensitive sites located upstream of the e-globin IL-4 promoter, that the intronic enhancer (IE) in the sec-
gene, the most 59 gene of the b-globin gene cluster. ond intron of the IL-4 gene and a region comprising
Constructs carrying the b-globin gene flanked by the DNase I hypersensitive sites HS5 and HS5a have weaker
LCR resulted in tissue-specific, high-level, copy num- enhancer activity on the IL-4 promoter, and that ele-
ber–dependent, and position-independent expression ments in the 39 region of the IL-4 gene contribute to the
in transgenic mice (Grosveld et al., 1987). The presence Th2 specificity of IL-4 promoter activity. However, these
of an LCR can be tested by measuring the ability to elements were not sufficient either separately or to-
confer copy number–dependent and integration site– gether to act as an LCR. Introduction of GATA-3 induced
independent expression to linked genes in transgenic strong enhancement of IL-4 promoter activity in Th1
mice. The action of LCRs and many but not all enhancer cells when the promoter was linked to HSS and IE or
elements is only demonstrable when integrated into was in a “minilocus,” strongly suggesting that GATA-3
chromatin. For this reason, it is more informative to study acts through these enhancer regions to induce IL-4 gene
the role of distal regulatory regions of the IL-4 gene expression.
using a transgenic mouse approach, in which promoter
and reporter genes are in the context of endogenous Results
chromatin, rather than with transient transfection assays,
in which promoter and reporter genes are extrachromo- To search for distal regulatory elements in the IL-4 locus,
somal. such as an enhancer or LCR, we chose two kinds of
The transcription factor GATA-3 appears to be the candidates for regulatory elements. One was the pre-
key transcription factor to induce Th2 cell differentiation viously published DNase I hypersensitive sites located
(Zhang et al., 1997; Zheng and Flavell, 1997; Ouyang et near the IL-4 gene (Agarwal and Rao, 1998; Takemoto
al., 1998, 2000; Lee et al., 2000). GATA-3 is selectively
et al., 1998). In addition, we searched for conserved
expressed in Th2 cells, antisense GATA-3 inhibits the
regions between human and mouse around the IL-4
expression of Th2 cytokines, and elevated GATA-3 in
gene. By sequence comparison we found several re-
CD4 T cells caused Th2 cytokine expression in Th1 cells
gions in the IL-4 locus that are conserved between hu-in transgenic mice (Zheng and Flavell, 1997). Ectopic
man and mouse DNA. Figure 1A shows the publishedGATA-3 expression induced by retrovirus infection
DNase I hypersensitive sites and conserved regions.blocks IL-12 receptor expression and induced a Th2
Most of the conserved regions overlap with DNase Iphenotype in developing Th1 cells and committed Th1
hypersensitive sites such as HSS, IE and HS5, implyingcells (Ouyang et al., 1998; Lee et al., 2000). Introduction
an evolutionarily conserved role in these sites. The onlyof GATA-3 into STAT6-deficient T cells restored Th2
conserved region that does not overlap with DNase Idevelopment (Ouyang et al., 2000). Moreover, GATA-
hypersensitive sites is HM1 (Figure 1). In addition, HS43-dependent enhancer activity has been found within
is hypersensitive, but the sequence in this region is notseveral global regions surrounding the IL-4 gene by tran-
strongly conserved.sient transfection assays (Ranganath et al., 1998), al-
We generated reporter constructs with the 800 bp IL-4though the specific targets are not known. These results
promoter 1 luciferase with or without various regionssuggest possible involvement of GATA-3 in the regula-
comprising DNase I hypersensitive sites or conservedtion of IL-4 gene expression at multiple levels.
sequences, as shown in Figure 1B. We made transgenicTo elucidate the mechanism for IL-4 gene expression
mice containing these constructs and determined theacting at the chromatin level, we searched for distal cis-
transgene copy number of the mice (see Experimentalacting elements for IL-4 gene expression, such as distal
Procedures). To check IL-4 promoter activity under Th1/enhancers or LCRs, and investigated their role with re-
Th2 differentiation conditions, splenic CD4 T cells fromgard to GATA-3. In a search for the distal regulatory
the transgenic mice were isolated and stimulated withelements we used two approaches. In the first, we inves-
Con A 1 APC under either Th1 or Th2 skewing conditionstigated whether the DNase I hypersensitive sites pre-
for 3 days and then restimulated with Con A for 12 hr.viously published have any regulatory role on IL-4 gene
Cell extracts were prepared, and luciferase activity wasexpression by investigating transgenic mice in which
measured with the same amount of protein. Luciferasethe IL-4 promoter–luciferase reporter was linked with
measurements with the extracts were made multiplethese putative regulatory sites. In the second approach,
we identified DNA regions homologous between human times on different occasions and were found to be highly
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Figure 1. DNase I Hypersensitive Sites and
Conserved Regions around the IL-4 Locus
and Constructs for Transgenic Mice
(A) DNase I hypersensitive sites and con-
served regions around the IL-4 locus. Arrows
indicate DNase I hypersensitive sites, and ho-
rizontal bars indicate the conserved regions.
(B) Constructs for transgenic mice.
reproducible. For each construct, we used animals de- transgenic mice that have DNase I hypersensitive sites
rived from several different founders. or conserved regions in addition to the identical segment
In this study, CD4 T cell stimulation and measurement of the IL-4 promoter 1 luciferase gene.
of luciferase were carried out at multiple occasions at
different time points. We were concerned about inter-
The Intergenic Regulatory Region Exhibits Strongsample variation, and, to correlate reporter gene tran-
Enhancer Activity on the IL-4 Promoterscription with expression of the endogenous gene, we
The intergenic (HSS) region located between the IL-4measured IL-4 production in the supernatant of each
and IL-13 genes was found to contain Th1/Th2 differenti-sample used in this study as an internal control for the
ation-specific DNase I hypersensitive sites (Takemotoluciferase activity. Mean 6 standard deviation (SD) of
et al., 1998). Our sequence comparisons of human andthe amount of IL-4 per unit protein was 0.61 6 0.19
mouse DNA showed that there is a highly conserved(U/mg protein), indicating that this range of variability
400 bp sequence (about 80% homology) in the HSSdoes not affect the interpretation of our results.
region. Recently, Loots et al. (2000) reported that the
deletion of this 400 bp conserved region (termed theControl IL-4P Transgenic Mice
conserved noncoding sequence [CNS-1] in their study)As previously reported (Wenner et al., 1997) and as con-
in a human YAC transgenic mouse caused about 70%firmed in the transgenic mice of our present study, the
reduction of human IL-4-producing cells, about 50%800 bp IL-4 promoter (IL-4P) directs little luciferase ac-
reduction of human IL-13-producing cells, and 50% re-tivity (Figure 2A). The level of luciferase activity of the
duction of human IL-5 production and proposed thatIL-4P-luc mice ranged from 1500 to 4000 RLU per 15
this element was a coordinate regulatory region for themg protein in Th2 cells. This activity is 3- to 4-fold greater
Th2 cytokine gene cluster. To ensure that we incorpo-in Th2 cells compared with Th1 cells and 12- to 30-fold
rated all three DNase I hypersensitive sites and theincreased compared with naive CD4 T cells. The 3- to
CNS-1, we utilized a 2.7 kb segment encompassing4-fold induction of luciferase activity in Th2/Th1 cells in
these elements. Figure 2B shows the luciferase activityour study is less than that of previous work by Wenner
of the HSS-IL-4P transgenic mice. Four out of eightet al. (1997), who found an z40-fold induction. This dif-
transgenic mice (21-8, 26-10, 30-5, and 28-14) showedference could be due to different experimental condi-
very strong enhancement of luciferase activity rangingtions, such as different stimulation (Con A versus cog-
from 116,000 to 273,000 RLU in Th2 cells, an increasenate peptide) and restimulation (Con A versus PMA 1
of 35- to 90-fold compared with control IL-4P transgenicionomycin) methods. However, Th2 specificity is clearly
mice. However, the luciferase activity in these lines wasseen in both studies. The luciferase activity of these
not Th2 specific, with even higher activity in Th1 cells.transgenic mice was not copy number dependent. We
used these mice as a control for comparison with other The other transgenic lines, 24, 4, 16, and 14, showed
Immunity
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Figure 2. Luciferase Activity in IL-4P and
HSS-IL-4P Transgenic Mice
Splenic CD4 T cells were isolated from trans-
genic mice, and 3 3 106 CD4 T cells were
cultured in 5 ml of Bruff’s medium (with the
same number of APC) in the presence of 2.5
mg/ml Con A and 20 U/ml IL-2 (under the Th1
or Th2 skewing conditions) for 3 days,
washed, and restimulated with 2.5 mg/ml Con
A for 12 hr. Cell extracts were made, and
luciferase activity was measured with 15 mg
of protein. (A) IL-4P transgenic mice. (B) HSS-
IL-4P transgenic mice.
luciferase activity ranging from 100 to 5700 RLU in Th2 be a mast cell–specific enhancer (Henkel et al., 1992).
Later, it was found that the IE region hypersensitive sitescells, which was either no increase or a modest 2-fold
increase compared with control IL-4P transgenic mice. were also present in Th2 cells (Agarwal and Rao, 1998).
To test enhancer activity, we linked this region to theThe level of IL-4 produced by the Th2 cells from these
low expressors was not significantly different from the IL-4P-luc construct, generated transgenic mice, and as-
sayed luciferase activity in Th2 and Th1 effector cellslevels produced by the high-expressing lines (data not
shown). The inactivity of the enhancer in these lines is (Figure 3A). IL-4P-IE transgenic mice showed luciferase
activity ranging from 440 to 23,200 RLU in Th2 cells,likely to be due to the inhibition of this element caused
by integration into the vicinity of heterochromatin (Fes- which ranged from no increase to a 2- to 7-fold increase
tenstein et al., 1996). This result shows that HSS can of luciferase activity compared with control IL-4P mice.
strongly enhance IL-4 promoter activity, but this region Additionally, the luciferase activity was Th2 specific in
alone does not confer Th2 specificity on the IL-4 pro- five out of seven lines. In an exceptional case, one of the
moter. HSS-IL-4P transgenic mice did not show copy transgenic lines showed very strong luciferase activity
number–dependent luciferase activity. ranging from 64,000 to 31,000 RLU (25- to 125-fold in-
crease) in Th2 cells. This line, however, did not show
Th2 specificity (data not shown). Overall, these resultsThe Intronic Enhancer and the HS5/HS5a Region
Exhibit Enhancer Activity on the IL-4 Promoter show that the IE region has weak enhancer activity on
the IL-4 promoter and that the activity is generally Th2The IE region was originally detected in mast cells as a
specific DNase I hypersensitive site and was shown to specific. This result also shows that the IE region does
Distal Regulatory Elements of the IL-4 Gene
451
Figure 3. Luciferase Activity in IL-4P-IE and
IL-4P-HS5 Transgenic Mice
Experiments were performed as in Figure 2.
(A) IL-4P-IE transgenic mice. (B) IL-4P-HS5
transgenic mice.
not confer copy number–dependent activity to the IL-4 genic mice, consistent with published activity of this
region. However, the luciferase activity was not Th2 spe-promoter.
The HS5 site, which is located in the 39 region of cific, yielding significantly greater activity in Th1 cells
in several lines. A single transgenic line, 26, was anthe IL-4 gene, was found to be a Th2-specific DNase I
hypersensitive site by Agarwal and Rao (1998). This re- exceptional case, which showed a 93-fold increase of
luciferase compared with control IL-4P transgenic micegion also has a 360 bp 83% conserved region between
human and mouse DNA. Recently, Agarwal et al. (2000) (data not shown). Overall, the results suggest that the
HS5/HS5a region has enhancing activity on the IL-4 pro-identified an activation-dependent Th2 effector cell–
specific inducible DNase I hypersensitive site, HS5a, moter, and our results confirm the relatively weak (2-fold)
enhancer activity recently described for this region byclosely linked to HS5, and they found that this region
has functional binding sites for GATA-3 and NFAT1 with Agarwal et al. (2000).
Th2 specificity. In transient transfection assays, they
found that this region gives about a 2-fold enhancement HS4 and HM1 Region Do Not Enhance
IL-4 Transcriptionof IL-4 transcription compared with the IL-4 promoter
alone. The HS5/HS5a segment we used for our study The HS4 site, which is located in the 39 region of the
IL-4 gene, was found to be hypersensitive to DNase Icontains both HS5 and HS5a. Figure 3B shows the lucif-
erase activity of IL-4P-HS5/HS5a transgenic mice. T in naive CD4 T cells, Th1, and Th2 cells (Agarwal and
Rao, 1998). Unlike other DNase I hypersensitive sites,cells from these mice showed luciferase activity ranging
from 200 to 13,000 RLU in Th2 cells, which was a 0.1- HS4 is constitutively sensitive both in Th1 and Th2 cells.
Moreover, the actual DNase I hypersensitivity in the HS4to 4-fold differential compared with control IL-4P trans-
Immunity
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site decreases in Th2 cells. Figure 4A shows the lucifer- IL-4 luciferase reporter. These transgenic mice showed
ase activity of IL-4P-HS4 transgenic mice. This trans- a strong enhancement of luciferase activity ranging from
genic line showed reduced luciferase activity ranging 10,000 to 2,500,000 RLU in Th2 cells, corresponding to a
from 88 to 1925 RLU, irrespective of their copy numbers, 4- to 1000-fold increase compared with IL-4P transgenic
with nine out of ten lines exhibiting a 2- to 25-fold reduc- mice (Figure 5B). Remarkably, all of these transgenic
tion of expression compared to the IL-4 promoter con- lines showed Th2 specificity. The luciferase ratio of Th2/
trols. Previous work by Kubo et al. (1997) using transient Th1 ranged from 5 to 15 for individual lines. In fact, the
transfection showed that this region might function as minilocus transgenics was the only set of transgenic
a Th1-specific silencer. Together, our results and those lines that displayed both high-level enhancer activity
of Kubo suggest that the HS4 region does not function and Th2 specificity. These results indicate that the HSS
as an enhancer for the IL-4 gene but rather that it may is responsible for strong enhancer activity, while one or
function as a suppressor/silencer. Obviously, the HS4 more of the 39 elements (HS4, HS5/HS5a, and HM1),
region did not show copy number–dependent luciferase possibly in combination with IE, contribute to Th2 speci-
activity. ficity; it remains to be determined which of the three 39
The HM1 region is one of the regions conserved be- regions might influence Th2 specificity. It is noteworthy
tween human and mouse DNA in the Th2 cytokine locus that minilocus transgenic mice did not show copy num-
and is located between the HS4 and HS5a sites. The ber–dependent luciferase activity, suggesting that the
360 bp HM1 region shows 81% sequence conservation elements in the minilocus, as configured in this study,
between human and mouse DNA. Similar to the results are not sufficient to act as an LCR and that the minilocus
obtained with HS4, IL-4P-HM1 transgenic mice showed construct is susceptible to inhibitory effects of hetero-
a reduction of luciferase activity in six out of eight trans- chromatic regions at integration sites of several of the
genic lines, with luciferase ranging from 132 to 563 RLU, transgenic lines (Festenstein et al., 1996). However,
irrespective of copy number (Figure 4B), corresponding these experiments do not rule out the possibility that
to a 4- to 20-fold inhibition of IL-4 promoter activity. there might be an effect of the context in which these
In many cases in the literature (Giese et al., 1995; DNA elements have been juxtaposed, which masks pu-
Thanos and Maniatis, 1995), regulatory elements act in tative LCR function.
concert to perform their functions. For instance, it has
been proposed that LCRs exert their full function only GATA-3 Acts through Combination of HSS and IE
when they have most or all of the necessary regions Enhancer Regions to Induce IL-4 Gene Expression
in transgenic mice (Milot et al., 1996), although some Since GATA-3 appears to be the key transcription factor
individual hypersensitive sites have been shown to have to induce Th2 differentiation (Zhang et al., 1997; Zheng
LCR activity with a reduced level (Fraser et al., 1993). and Flavell, 1997; Ouyang et al., 1998, 2000; Lee et al.,
Since the putative enhancer regions used individually 2000), we investigated whether GATA-3 mediates its
did not possess apparent LCR activity or provide Th2 action on IL-4 gene expression through the enhancer
specificity for IL-4 promoter activity, we were interested
and regulatory regions that we and others have defined.
to test the hypothesis that these activities (Th2 specific-
All enhancer elements (HSS, IE, and HS5/HS5a), whether
ity and/or LCR activity) might become manifest when
strong or not, have several consensus GATA-3 sites.particular combinations of these enhancer regions are
We introduced GATA-3 by using a retroviral vector con-used in these assays. To test this hypothesis, we made
taining an IRES-driven green fluorescence protein (GFP)transgenic mice with the following constructs: (1) HSS-
gene into naive splenic CD4 T cells from control IL-4P,IL-4P-IE, which contains IL-4P, HSS, and IE, and (2)
HSS-IL-4P, IL-4P-IE, IL-4P-HS5/HS5a, HSS-IL-4P-IE,a putative minilocus, which contains all the DNase I
and minilocus transgenic mice and stimulated thesehypersensitive sites and conserved regions used in this
cells using either Th1 or Th2 skewing condition. Sincestudy (i.e., IL-4P, HSS, IE, HS4, HS5/HS5a, and HM1
prior studies showed that GATA-3 enhanced the produc-[see Figure 1]).
tion of IL-4 by Th1 cells independently of IL-4 in the
culture medium (Zheng and Flavell, 1997; Ouyang et al.,Combining HSS and IE Regions Does Not Show
1998, 2000; Lee et al., 2000), we used this assay forIncremental Effects on IL-4 Promoter Activity
GATA-3 responsiveness of the individual regulatory ele-HSS-IE transgenic mice showed luciferase activity rang-
ments. Since minilocus transgenic mice showed a wideing from 6,100 to 43,700 RLU in Th2 cells, a 2- to 15-
range of expression, we analyzed one line exhibitingfold enhancement compared with IL-4P transgenic mice
relatively low-level expression and one line with high-(Figure 5A). Although a limited number of transgenic
level expression to ensure that effects of integration sitemice were analyzed, HSS-IL-4P-IE transgenic mice did
were controlled for. After 4 days, GFP-positive cells werenot show Th2 specificity nor did they show copy num-
separated from GFP-negative cells, restimulated, andber–dependent expression. This result suggests that
luciferase activity was measured. Figure 6 shows thatcombining the HSS and IE regions alone does not pro-
luciferase activity in Th1-stimulated cells from controlvide additive or synergistic effects on the enhancement
IL-4P (A), HSS-IL-4P (B), IL-4P-IE (C), and IL-4P-HS5/5aof IL-4 gene transcription.
(D) transgenic mice was not influenced by introduction
of GATA-3, suggesting that these regions are not individ-Combination of the Regulatory Regions into
ually responsive to GATA-3. Strikingly, luciferase activitya Minilocus Confers Both Strong Enhancement
in Th1-stimulated cells from HSS-IL-4P-IE and minilocusand Th2 Specificity on IL-4 Promoter Activity
transgenic mice was increased about 10-fold to the levelIn the minilocus construct, we combined all the elements
studied above, in the appropriate orientation, with the seen in Th2 cells by the introduction of GATA-3 (Figures
Distal Regulatory Elements of the IL-4 Gene
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Figure 4. Luciferase Activity in IL-4P-HS4
and IL-4P-HM1 Transgenic Mice
Experiments were performed as in Figure 2.
(A) IL-4P-HS4 transgenic mice. (B) IL-4P-HM1
transgenic mice.
6E–6G). Importantly, GATA-3 enhanced the expression Brown and Hural, 1997; Li-Weber et al., 1997; Rinco´n
and Flavell, 1997; Szabo et al., 1997; Murphy, 1998;of both high- and low-expressing minilocus transgenic
mice to an equal extent (Figure 6). This result clearly Glimcher and Murphy, 2000), distal elements that regu-
late IL-4 gene expression have not been extensivelyshows that GATA-3 exerts its function through this com-
bination of enhancer regions (HSS, IE, and, as previously studied. Based on the data of Wenner et al. (1997) using
the 800 bp IL-4 promoter 1 luciferase transgenic mice,shown, HS5/5a [Agarwal et al., 2000]) to induce IL-4
gene expression. This result also supports the previous this 800 bp IL-4 promoter is not sufficient to give endog-
enous level of expression, and we confirmed this resultreports that GATA-3 induces Th2 differentiation inde-
pendent of IL-4 (Zheng and Flavell, 1997; Ouyang et al., in our present study. To locate the DNA sequences re-
sponsible for a high-level tissue-specific expression, we1998; Lee et al., 2000).
searched for distal regulatory elements, which regulate
IL-4 gene expression. Using a transgenic approach, weDiscussion
found that the HSS region has strong enhancer activity
on the IL-4 promoter, that IE and HS5/HS5a regionsRegulation of IL-4 gene expression is critically important
for the understanding of Th1/Th2 immune response, have weaker enhancer activity, and that regions 39 of
the IL-4 gene confer Th2 specificity on the enhancedsince IL-4 is a key inducing factor for Th2 differentiation
and therefore a key mediator of the Th2 immune re- IL-4 promoter. However, we found that all the elements
used in this study either separately or combined weresponse. Compared to several detailed studies of the
proximal IL-4 promoter/enhancer region (reviewed by not sufficient to function as an LCR. The mechanisms
Immunity
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Figure 5. Luciferase Activity in HSS-IL-4P-IE
and Minilocus Transgenic Mice
Experiments were performed as in Figure 2.
(A) HSS-IL-4P-IE transgenic mice. (B) Minilo-
cus transgenic mice. One minilocus trans-
genic line failed to express the transgene
(line 97).
that underlie this distal regulation include GATA-3, though it is clearly a strong enhancer. Considering the
data from Loots et al. and our present study, it is possiblewhich exerts its function to activate IL-4 gene expres-
sion through these enhancers. that this region may be an essential and necessary part
of an as yet hypothetical LCR that controls coordinateThe HSS region was found to be DNase I hypersensi-
tive by Takemoto et al. (1998). This region contains three expression of all three cytokine genes in this cluster; it
is not, however, sufficient to act as an LCR either aloneDNase I hypersensitive sites, HSS1, HSS2, and HSS3.
HSS3 is hypersensitive in Th1, Th2, and naive CD4 T or when combined with the other elements in our study.
To assay for enhancer activity in transient transfections,cells, but HSS1 and HSS2 are specifically induced in Th2
cells. The HSS region used for our studies comprised a which is the conventional approach, we transfected the
HSS-IL-4P construct into the Th2 cell line D10, stimu-2.7 kb fragment containing all three HSS sites, HSS1–3.
Within this HSS region, there is a 400 bp region of highly lated the cells with PMA 1 ionomycin, and determined
luciferase activity. The luciferase activity in HSS-IL-4Pconserved segments, which exhibits 83% sequence
identity between human and mouse. Recently, Loots et transfected cells was not increased compared to that
in control IL-4P transfected cells (data not shown), sug-al. (2000) proposed that this 400 bp element (CNS-1)
was a coordinate regulatory region for the Th2 cytokine gesting that the enhancer activity of HSS functions spe-
cifically in a chromosomal context. This 400 bp con-gene cluster. Our HSS-IL-4P transgenic data, however,
show that the HSS region by itself is not an LCR, al- served region (CNS-1) also contains a GATA-3 binding
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Figure 6. GATA-3-Dependent Luciferase Activity in Transgenic Mice
Naive CD4 T cells (2 3 105) were stimulated with 2.5 mg/ml Con A, 25 U/ml IL-2, and 6 3 106 APC in 1.5 ml Bruff’s medium at day 0 and
infected with 1.5 ml viral supernatant containing either control retroviral vector (GFP-RV) or GATA-3 expression retroviral vector (GATA3-RV)
in either the Th1 or Th2 skewing condition at day 1. GFP-positive T cells were isolated by cell sorting at day 5 and restimulated with 2.5 mg/
ml Con A for 20 hr. Cell extracts were made, and luciferase activity was measured. Luciferase activity was normalized to 15 mg of protein.
(A) IL-4P, (B) HSS-IL-4P, (C) IL-4P-IE, (D) IL-4P-HS5, (E) HSS-IL-4P-IE, (F) minilocus (low), and (G) minilocus (high) transgenic mice. Two lines
of minilocus transgenic mice (F and G) were used for this experiment: one ([F], line 30) shows low and the other ([G], line 54) shows high
enhancement of IL-4 promoter activity.
site. Recently, it has been shown that GATA-3 binds to cently, Hural et al. (2000) have shown that this region is
important in regulating IL-4 gene locus accessibility inthis site in Th2 nuclear extracts as expected but not in
Th1 nuclear extracts (Takemoto et al., 2000). mast cells. This region also contains one consensus
GATA-3 binding site (WGATAR), which binds a proteinThe IE region was originally found as a mast cell–
specific enhancer by Henkel et al. (1992). They found likely to be GATA-3 in EL-4 cells (Henkel and Brown,
1994), as well as several putative GATA-3 binding sites.DNase I hypersensitivity in the IE region and enhancer
activity by transient transfection assay in mast cell lines HS5 was found to be DNase I hypersensitive in Th2
cells by Agarwal and Rao (1998). Recently, Agarwal etbut not in the T lymphocytic cell line EL-4. Agarwal and
Rao (1998) showed, however, that this region is DNase al. (2000) reported a Th2 effector cell–specific inducible
DNase I hypersensitive site, 5a, closely linked to HS5,I hypersensitive in the Th2 clone D10 and differentiating
Th2 cells derived from mouse CD4 T cells. Our study and they found that this region has functional binding
sites for GATA-3 and NFAT1 with Th2 specificity. Byclearly shows that this region has enhancer function
when integrated into mouse chromosomes. We also sequence comparison, we found that the HS5/HS5a re-
gion contains a 360 bp highly conserved region compris-found that IE, like HSS, did not show enhancer activity
in transient transfection assays (data not shown), sug- ing an 83% identical match between human and mouse
DNA. The HS5/HS5a region shows weak enhancer activ-gesting that IE also functions specifically in a chromo-
somal context. This region is also highly conserved, ity (about 0.1- to 4-fold increase compared with control)
in our transgenic mouse study. In transient transfectionshowing 67% sequence identity over 680 bp, between
human and mouse. By using a mobility shift assay, it has assays, Agarwal et al. (2000) found that this region gives
about a 2-fold increase in IL-4 transcription comparedbeen found that transcription factors GATA-1, GATA-2,
PU.1, STAT5a, and STAT5b bind to this region in mast with the IL-4 promoter alone. Unlike the HSS and IE
enhancers, the level of enhancement of IL-4 transcrip-cells (Henkel and Brown, 1994; Hural et al., 2000). Re-
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tion by HS5a is comparable in both transgenic mice and found that using separate elements or even combining
all the elements we studied was not sufficient to revealtransient expression systems.
The HS4 site was found to be DNase I hypersensitive an LCR. The failure of LCR activity of these elements
can be explained by two observations. One is that thesein Th1/Th2 cells by Agarwal and Rao (1998). Unlike other
DNase I hypersensitive sites, HS4 is constitutively sensi- elements of the IL-4 gene region did not confer copy
number–dependent expression to the linked luciferasetive in Th1, Th2, and naive CD4 T cells. In fact, the DNase
I hypersensitivity of the HS4 site decreases in Th2 cells reporter in our transgenic mice. The other is that some
transgenic mice showed very low (four out of eight HSScompared with Th1 cells (Agarwal and Rao, 1998). Our
HS4 transgenic mice result showed results consistent transgenic mice; Figure 2B) or relatively low (four out
of ten minilocus transgenic mice; Figure 5B) reporterwith a repressor function for HS4 (Figure 4A). Interest-
ingly, this feature of decrease in DNase I hypersensitivity activity, suggesting that the transgenes in these mice
were subjected to position effect variegation. It is possi-and a putative repressor function of HS4 resembles the
observations of the 22.4 kb silencer region of the ble, however, that we have not yet included other essen-
tial elements or parts of an LCR.chicken lysozyme locus, in which constitutive DNase
I hypersensitivity decreases with the differentiation of In this study, we demonstrated that GATA-3 exerts
its function to activate IL-4 gene expression throughtranscriptionally inactive precursor cells to transcrip-
tionally active macrophages (Huber et al., 1995; Bonifer distal enhancers, HSS and IE (Figure 6). It is likely that
GATA-3 is the key factor in Th2 differentiation (Zhanget al., 1996).
Using a transient transfection assay, Kubo et al. (1997) et al., 1997; Zheng and Flavell, 1997; Ouyang et al.,
1998, 2000; Lee et al., 2000). Our present study furtherreported a Th1-specific silencer element in the 39 region
of the IL-4 gene and that STAT6 binding to this element supports this conclusion and sheds light on the mecha-
nism whereby GATA-3 induces Th2 differentiation byhas a permissive role in Th2 differentiation. Of the 1270
bp silencer region, our HS4 region covers the latter 938 providing clear evidence that GATA-3 is directly involved
in IL-4 locus regulation through distal enhancers.bp including the STAT6 site but lacks the first 332 bp,
which contains several binding sites for transacting fac- Although how GATA-3 acts in Th2 cell differentiation is
not clear, recent publications have suggested a possibletors, such as Ikaros, Oct, GATA, Ets, and myc. Since our
HS4 transgenic mice data showed that IL-4 transcription role of GATA-3 in chromatin remodeling. Ectopic expres-
sion of GATA-3 induced Th2-specific DNase I hypersen-was repressed even in Th2 cells, it can be interpreted
that either STAT6 does not function to relieve the repres- sitive site (or sites) in Th1 cells (Lee et al., 2000) and in
STAT6-deficient cells (Ouyang et al., 2000). Since oursive effect in this region in a more physiologic transgenic
mice system or that STAT6 needs other factors to per- study shows that GATA-3 acts through HSS and IE (and
possibly HS5/HS5a) regions for IL-4 locus regulation, itform its function. It will be interesting to determine
whether the missing 332 base pair region of the silencer is possible that GATA-3 associates to these enhancer
regions to induce chromatin remodeling. In support ofregion acts through cooperation with STAT6 to relieve
repression of IL-4 transcription in Th2 cell differentiation this possibility, it has been shown that GATA-1, another
member of the GATA family, induces formation of DNasein transgenic mice.
None of the individual elements that we have studied I hypersensitive sites in the human b-globin LCR (Stama-
toyannopoulos et al., 1995) and in the chicken b-globinconfer both strong and Th2-specific enhancement to
the IL-4 promoter. Combination of all the elements we gene (Boyes and Felsenfeld, 1996).
Consistent with our observation that GATA-3 targetsused in this study into a minilocus does, however, confer
strong Th2-specific enhancement of IL-4 promoter ac- HSS and IE, it has been shown recently that GATA-3
binds to HSS (Takemoto et al., 2000), IE (Henkel andtivity. This result suggests that IL-4 regulatory elements
are composed of several components, which must func- Brown, 1994), and HS5a (Agarwal et al., 2000) regions by
gel shift assay or chromatin immunoprecipitation assay.tion cooperatively to give optimal differentiation state–
specific expression to the IL-4 gene, while each compo- However, the possibility that GATA-3 performs its action
without direct DNA binding, possibly by protein–proteinnent potentially has distinct functions. This result is
somewhat reminiscent of the enhanceosome described association with other factors, cannot be excluded,
since a mutant GATA-3 lacking the N-terminal zinc fingerfor the IFNb promoter by Thanos and Maniatis (1995).
The Th2 cytokine genes IL-4, IL-5, and IL-13 are clus- and lacking DNA binding ability can induce IL-4 expres-
sion in Th1 cells (Lee et al., 2000). The detailed role oftered within a 125 kb region (Loots et al., 2000). Since
these cytokines are coordinately expressed, it has been GATA-3 at the distal enhancers and the mechanism of
its action at these sites await further study.speculated that this Th2 cytokine locus might have
an LCR that controls the coordinate expression of Th2 Although all of the HSS, IE, and HS5/HS5a regions
have GATA-3 binding sites, as does the IL-4 promoter,cytokine genes (Flavell, 1999). An LCR is defined as a
regulatory element that confers copy number–depen- individual regions did not respond to GATA-3 to enhance
the IL-4 promoter activity in Th1 cells. However, whendent tissue-specific and developmental stage–specific
high-level gene expression in transgenic mice without HSS and IE were combined, the IL-4 gene responded
to GATA-3. Given the fact that GATA-3 requires a combi-being subject to interference from flanking sequences
at the integration site. We searched for an LCR in the nation of at least two enhancer regions for its action
and that these regions are distantly located (HSS andDNase I hypersensitive sites and interspecific conserved
DNA regions. Importantly, LCRs from several gene loci IE regions are located 4.5 kb apart in our HSS-IL-4P-IE
construct and 8.5 kb apart in the endogenous IL-4 locus),exhibit their function when taken out of their local con-
text and linked to reporter genes (Grosveld et al., 1987; we postulate that GATA-3, HSS, and IE may act in con-
cert, likely in cooperation with HS5/HS5a, to performGreaves et al., 1989; Diaz et al., 1994). However, we
Distal Regulatory Elements of the IL-4 Gene
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Determination of Copy Numbertheir function by forming a holocomplex, as was sug-
For Southern blotting, 10 mg of tail DNA was electrophoresed; trans-gested in b-globin LCR (Ellis et al., 1996). Consistent with
ferred to nylon membrane; prehybridized in the presence of 63 SSC,this, GATA-3 also enhanced the minilocus construct.
53 Denhardt’s solution, 0.5% SDS, and 100 mg/ml salmon sperm
Our study demonstrates that IL-4 gene expression is DNA at 658C for 2 hr; and hybridized with luciferase probe at 658C
controlled by distal regulatory elements such as en- for 16 hr. Membrane was washed and exposed to X-ray film and
phosphoimager. Band intensity was quantified by GS-525 phospho-hancers and elements, which confer differentiation
imager (Bio-Rad). Copy number was determined by comparing thespecificity, and that GATA-3 plays an important role in
band intensity of transgenic DNA with those of known amounts ofthe regulation of IL-4 gene expression through these
IL-4P construct digested with PstI (3 kbp), based on the assumptiondistal enhancers. Further, since the effects cannot be
that the mouse genome is 3 3 109 bp. We also checked the transgene
duplicated in transient transfection, this mechanism copy number by comparing transgenic IL-4 promoter with endoge-
likely works at the chromatin level. This study further nous IL-4 promoter, which gave comparable results within the error
of these measurements.supports the importance of regulation at the chromatin
level during differentiation. A detailed study on the role
of GATA-3 in the regulation process and the search for In Vitro Differentiation of CD4 T Cells
CD4 T cells were enriched from spleen cells from transgenic micean IL-4 LCR remain to be performed.
by negative selection through depletion using anti-MHC class II (M5/
115), anti-NK1.1 (HB191), and anti-CD8 (53–6.7) mAb, followed by
depletion with a mixture of magnetic beads conjugated to anti-ratExperimental Procedures
Ig and anti-mouse Ig antibodies (Perseptive Biosystems). The purity
of the cells was usually greater than 90%. APCs were prepared byPlasmid Construction
g irradiation and negative selection (Zheng and Flavell, 1997). TopGL3-IL-4P construct was made by inserting the 800 bp promoter
differentiate CD4 T cells in vitro, 3 3 106 CD4 T cells were culturedregion from 2741 to 160 of the transcription start site (cloned by
with an equal number of APC in 5 ml of Bruff’s medium with 5%PCR using BamHI-tagged primers) into the BglII site of pGL3-basic
fetal calf serum (Life Technologies, Inc.) and penicillin/streptomycinluciferase vector (Promega). For better expression of luciferase gene
in the presence of 2.5 mg/ml Con A and 20 U/ml IL-2. For Th1in transgenic mice, the SV40 late poly (A) signal was replaced with
skewing conditions, 3.5 ng/ml murine rIL-12 (generous gift fromhuman growth hormone (hGH) poly (A) signal by removing the 262
Genetics Institute) and 11B11 (anti-IL-4) Ab were added, and, forbp XbaI–BamHI fragment and inserting a 2142 bp PCR-cloned hGH
Th2 skewing condition, 1000 U/ml IL-4 and XMG1.2 (anti-IFN-g) Abpoly (A) signal (generous gift from Dr. S. Ghosh). This pGL3-IL-4P
were added. After 3 days, cells were washed and restimulated withconstruct was used as the basis for other constructs. The pGL3-
2.5 mg/ml Con A for 12 hr. Under Th2 conditions, IL-4 productionIL-4P-IE construct was made by inserting a 679 bp BglII fragment
was 0.61 6 0.19 U/mg protein.from the second intron of the IL-4 gene from the pIL-4 plasmid
(generous gift from Dr. R. Leder) into the BamHI site of pGL3-IL-
4P. The pGL3-HSS-IL-4P construct was made by inserting a 2738 Luciferase Activity Assay
bp fragment from 210463 to 27725 bp upstream of the IL-4 transla- Cell extracts were made from unstimulated or Th1/Th2 differentiated
tion start site (cloned by PCR using NheI-tagged primers) into an cells. Protein concentration of the extracts was measured using
NheI site of the pGL3-IL-4P construct. The pGL3-IL-4P-HS4 con- Bio-Rad protein assay reagent. For the luciferase assay, 15 mg of
struct was made by inserting a 980 bp fragment from 520 to 1500 extract was used for luciferase activity assay with the Promega
bp downstream of the IL-4 translation stop site (cloned by PCR luciferase assay substrate. Luciferase activity was measured by
using BamHI-tagged primers) into the BamHI site of the pGL3-IL- Lumat LB9507 luminometer (EG&G Wallac).
4P construct. The pGL3-IL-4P-HS5/5a construct was made by in-
serting a 2128 bp fragment from 5051 to 7179 bp downstream of
GATA-3 Retroviral Transduction into Naive CD4 T Cells
the IL-4 translation stop site (cloned by PCR using BamHI-tagged
Naive CD4 T cells were isolated by sorting CD44lowCD45RBhigh cells,
primers) into the BamHI site of the pGL3-IL-4P construct. The pGL3-
using a cell sorter (Becton Dickinson), from splenic CD4 T cells from
IL-4P-HM1 construct was made by inserting a 719 bp fragment from
transgenic mice described above. The control retroviral vector GFP-
2257 to 2976 bp downstream of the IL-4 translation stop site (cloned
RV and GATA-3 expression retroviral vector GATA-3-RV were a
by PCR using BamHI-tagged primers) into the BamHI site of the
generous gift from Dr. K. Murphy (Ranganath et al., 1998). 293 (Phoe-
pGL3-IL-4P construct. The pGL3-HSS-IL-4P-IE construct was made
nix) packaging cells were transfected as previously described (Ran-
by inserting a 2738 bp fragment from 210463 to 27725 bp upstream
ganath et al., 1998). Naive CD4 T cells (2 3 105) were stimulated
of the IL-4 translation start site (cloned by PCR using NheI-tagged
with 2.5 mg/ml Con A, 25 U/ml IL-2, and 6 3 106 APC in 1.5 ml
primers) into the NheI site of the pGL3-IL-4P-IE construct. To make
Bruff’s medium at day 0 and infected with 1.5 ml viral supernatant
the pGL3-minilocus construct, the 719 bp HM1 region, 980 bp HS4
containing either control or GATA-3 retroviral vector and reagents
region, and 2128 bp HS5/HS5a region were first combined into
for either Th1 or Th2 skewing condition described above at day 1.
pBluescript SK (1) vector. The HM1-HS4-HS5/51 region was cut
GFP-positive T cells were isolated by cell sorting at day 5 and
out from this construct by SalI digestion and inserted into the SalI
restimulated with 2.5 mg/ml Con A for 20 hr. Cell extracts were
site of pGL3-HSS-IL-4P-IE. The sequences of all the PCR products
made, and luciferase activity was measured as described above.
were confirmed by sequencing.
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